Sun Pharma Group Stocks

1 Yr CAGR
34.07%
3 Yr CAGR
24.58%
Total Companies
3

News about Sun Pharma Stocks in India

Sun Pharma Adv. Res - Quaterly Results

A decrease of about -39.28% in the sales to Rs. 128.60 millions was observed for the quarter ended September 2024. The sales stood at Rs. 211.80 millions during the similar quarter previous year.The Net Loss for the quarter ended September 2024 is Rs. -1076.90 millions as compared to Net Loss of Rs. -864.20 millions of corresponding quarter ended September 2023 Operating profit Margin for the quarter ended September 2024 further decreased to -1038.10% as compared to -829.80% of corresponding quarter ended September 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 128.60 211.80 -39.28 296.70 451.30 -34.26 755.50 2387.80 -68.36
Other Income 0.40 84.90 -99.53 16.00 186.80 -91.43 294.70 108.80 170.86
PBIDT -1038.10 -829.80 25.10 -1973.70 -1749.70 12.80 -3743.20 -2031.80 84.23
Interest 11.10 2.60 326.92 16.30 5.20 213.46 16.60 76.30 -78.24
PBDT -1049.20 -832.40 26.05 -1990.00 -1754.90 13.40 -3759.80 -2108.10 78.35
Depreciation 27.70 31.80 -12.89 55.30 62.80 -11.94 121.30 117.70 3.06
PBT -1076.90 -864.20 24.61 -2045.30 -1817.70 12.52 -3881.10 -2225.80 74.37
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -1076.90 -864.20 24.61 -2045.30 -1817.70 12.52 -3881.10 -2225.80 74.37
Equity 324.50 324.50 0.00 324.50 324.50 0.00 324.50 324.50 0.00
PBIDTM(%) -807.23 -391.78 106.04 -665.22 -387.70 71.58 -495.46 -85.09 482.27
04 Nov, 2024
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.